Singapore Translational Cancer Consortium (STCC)  joint platform  enables  collaboration  between basic, clinical and translational researchers  to  explore novel  approaches,  push  promising  lines  of  research and translation, and seed ideas for larger competitive translational grants.

It is now in Phase 1 implementation, focusing on the operationalization of the four platforms: 

 

---

---